How can I test InheriNext® capabilities?
Compass Bioinformatics offers a four-stage process to test InheriNext, including a personal demonstration, a trial with sample or your own data, a pilot license, and custom integration. This ensures the platform meets your specific needs and integrates seamlessly into your workflow.
What variant types does InheriNext® support?
InheriNext® and InheriNext® Edge (RUO) support various variant types depending on the sequencing method. For WGS, it supports SNV, Indel, CNV, MT, SV, STR. For WES, it supports SNV, Indel, CNV, and for WES + MT, it supports SNV, Indel, CNV, MT.
Does InheriNext® follow ACMG guidelines for variant interpretation?
Yes, InheriNext® evaluates variant pathogenicity based on ACMG guidelines, classifying variants using 28 criteria. It automates up to 17 ACMG criteria and provides detailed explanations for those criteria, enhancing transparency and clinical judgment.
Can I customize reports and create my own presets in InheriNext®?
Yes, report sections are customizable with toggle on/off buttons. For customized presets, you can create them under Profile > Panel > Phenotype Set or Gene Panel set. Further customization needs can be discussed directly with Compass Bioinformatics.
What pricing models are available for InheriNext®?
InheriNext® offers transparent pricing models including annual licenses, per-report options, and collaborative partnerships. They are open to discussing contract terms at any stage of the trial to ensure a mutually beneficial relationship.